Skip to main content
Clinical Trials/NCT04240262
NCT04240262
Recruiting
Not Applicable

Prospective Observational Trial of Microwave Ablation for Leiomyoma (MYOMIC2)

Karolinska Institutet1 site in 1 country200 target enrollmentJanuary 20, 2020
ConditionsUterine Fibroid

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Uterine Fibroid
Sponsor
Karolinska Institutet
Enrollment
200
Locations
1
Primary Endpoint
Symptom severity of uterine fibroids
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

This prospective observational study aims to evaluate the effectiveness and acceptability of percutaneous or vaginal ultrasound guided microwave ablation for the treatment of symptoms related to uterine fibroids. We will include 200 women.

Registry
clinicaltrials.gov
Start Date
January 20, 2020
End Date
July 31, 2024
Last Updated
3 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Helena Kopp Kallner

Senior consultant ob/gyn

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • premenopausal
  • no future child wish
  • acceptable risks for general anestesia or sedation
  • willing to comply with protocol

Exclusion Criteria

  • current or future child wish
  • bleeding disorder with increased risk of bleeding

Outcomes

Primary Outcomes

Symptom severity of uterine fibroids

Time Frame: 6 months post treatment

Score of validated form Uterine Fibroid symptom- Quality of Life questionnaire. minumum 0, maximum 100 where higher scores indicate higher symptom severity

Secondary Outcomes

  • Quality of Life score(6 months post treatment)
  • acceptability(2 hours post treatment and 6 months post treatment (+/- 2 weeks))
  • menstrual bleeding(6 months post treatment)

Study Sites (1)

Loading locations...

Similar Trials